tiple patients with medical management was reported in 1992, and medical treatment has since been more prominent in the literature. 12 In 1999, Rigamonti et al. provided the first large cohort comparisons between surgical and conservative treatment of SEA. Since then, there have been numerous reports of institutional experience with SEA that indicate continued controversy over optimal SEA management. 1, 3, 4, 7, 10, 11, 14, 18, 19, 20, 24 As a result, we sought to perform a systematic review and analysis of studies published since 1999 to identify recent trends in SEA characteristics and management strategies. To compare current management strategies to prior trends, we collected data from a previous analysis of pooled data from 915 cases that was reported by Reihsaus et al. in 2000. 17 
Methods
A PubMed keyword and Boolean search using ("spinal epidural abscess" OR "spinal epidural abscesses" AND [management OR treatment]) returned 429 results (Fig. 1) . Filters for the English language and publications after 1999 were applied, as the first study comparing operative and nonoperative management was published that year. 18 After identifying articles comparing operative to nonoperative treatment strategies for SEA, the references within those articles were further reviewed for additional relevant articles. We included only adult (greater than 18 years of age) studies, as risk factors and management differ between adult and pediatric groups. We excluded case reports and small series of less than 10 patients for lack of power, for failure of these studies to track patients over time, and to reduce introduction of selection bias in our analysis. We did not find any randomized prospective trials comparing operative and nonoperative management. We did not find any studies that included only nonoperative management. We did not include studies of only operative management because those articles did not directly compare operative versus nonoperative management in the same series of patients. We also excluded study reports without indications for conservative management, as inclusion of these studies would introduce selection bias with unclear reasons for why patients were chosen for medical management. Studies examining SEA as a result of a specific pathogen were also excluded, as they did not represent the general cohort of patients presenting with SEA.
Data from the articles meeting our inclusion criteria were pooled and included demographic characteristics, risk factors, medical comorbidities, presenting features, pathogens, abscess location, management, and outcomes. If an abscess location spanned multiple cord segments, the location would be classified based on the most rostral segment involved. Patients were stratified into 2 groups based on their neurological presentation: patients without neurological deficit, with or without back pain (Group 1), and patients with neurological deficits, including radiculopathy, paresis, and paralysis, with or without back pain (Group 2). Patients were further stratified into whether they were treated operatively or medically. Papers reporting the number of treatment failures were noted and their data were combined. Reishaus and colleagues' analysis of the literature on SEA from 1954 to 1997 was used as a historical control for comparison. 17 JMP pro 10 from SAS was used for all statistical calculations. A 2-sample test for equality of proportions without continuity correction was used to determine the variance of our aggregate data against the historical control. Fisher's exact test was used to determine the aggregate trend of whether patients would be treated operatively or medically based on their presenting neurological symptoms.
Results
A PubMed search using ("spinal epidural abscess" OR "spinal epidural abscesses" AND [management OR treatment]) returned a total of 429 results. Twelve articles were retrospective patient reviews comparing surgical to medical management of SEA that met our previously stated inclusion criteria (Table 1 ). All 12 studies were retrospective single-institution reviews; none were prospective studies of treatment. The oldest article was from 1999, and the most recently published article was from 2014. Data reported in these individual institutional reports were pooled for analysis.
Demographics
The largest case series included 355 patients, and the smallest included 30. 11, 21 Adding all cases together, a total of 1099 patients were included in the 12 studies. 1, 3, 4, 7, 10, 11, 14, 18, [19] [20] [21] 24 The average age range of patients was from 45 to 65 years with an overall average of 57.2 years. Sex percentages were 62.5% for males, and 37.5% for females; this was not significantly different from historical data (p = 0.13) 17 (Table 2) .
Risk Factors and Medical Comorbidities
Intravenous drug use was the most frequently reported risk factor, and it occurred in 22% of patients with SEA. This percentage was significantly higher than that reported in the historical data. Diabetes (27%) and hepatic disease (14%) were the most commonly reported medical comorbidities. Overall, risk factors and medical comorbidities were more frequently reported in the pooled current data than in the historical data (Table 3) .
Pathogens
The most common pathogen found in either blood or tissue cultures was Staphylococcus aureus (63.6%), with negative cultures (13.9%), gram-negative bacteria (8.1%), coagulase-negative Staphylococcus (7.5%), and Streptococcus species (6.8%) making up much smaller percentages. In the papers reporting S. aureus methicillin sensitivity, methicillin sensitivity (38.9%) was more common than methicillin resistance (19.9%). Reihsaus et al. reported a similar breakdown of pathogens, but there were significantly more negative cultures in the current data (Table 4) . 17 
Location
The most common abscess location in the current data was the lumbar spine (48%), followed by the thoracic spine (31%) and then the cervical spine (24%). This was dissimilar to the historical data, where the thoracic spine (42.6%) was the most common location followed by lumbar (30.8%) and cervical spine segments (26.6%) ( Table  5 , p < 0.01).
Presenting Symptoms
In the current literature search there was a large variance of presenting symptoms that authors chose to report, with most studies reporting patients presenting with back pain or motor weakness. Percentages in the current data were taken from the total number of patients among studies reporting that symptom. The most common symptoms were back pain (67%), motor weakness (52%), fever (44%), sensory abnormalities (40%), and bladder/bowel incontinence (27%). This ordering was similar to the historical comparison, with the exception of fever being more common than weakness. There were significantly more patients with back pain, fever, and motor weakness in the historical data. In contrast, the current pooled data reported significantly more sensory abnormalities (Table 6 ).
Medical Versus Surgical Management
The current pooled data showed that a majority of patients with SEA received surgical treatment (60%). However, when compared with historical data, a significantly greater percentage of patients received medical management (p < 0.01), and a smaller percentage received surgical management (Fig. 2 , p < 0.01). In the current pooled data, the major factor determining whether a patient received surgery was weakness or other neurological symptoms. Patient who had only back pain without other neurological sequelae were significantly more likely to receive medical management (Fig. 3 , p < 0.01).
Due to the different methodologies used by studies to examine outcomes, we did not pool outcome data in our analysis; however, individual studies were analyzed for general trends (Table 7) . For instance, Patel et al.
14 used the American Spinal Injury Association (ASIA) motor score to measure outcomes differences, but other authors created unique descriptive scales. With the exception of Curry et al., 7 none of the authors who examined statistical differences in management found a significant difference between the outcomes of patients treated medically and those treated surgically. 1, 3, 4, 10, 11, 14, 20, 24 Curry and colleagues found a statistically significant difference in medical and surgical treatment, with medical treatment failing and surgery subsequently required in a marked 49% of cases. Five authors discussed the group of patients who initially started out with medical treatment but eventually underwent surgery after their condition deteriorated, with this group accounting for 6%-49% of the cases reported in those articles. 7, 11, 14, 19, 20 Risk factors for failure of medical management included diabetes, C-reactive protein level > 115 mg/L, leukocytosis > 12 × 10 9 white blood cells/L, positive blood cultures, age > 65 years, methicillin-resistant S. aureus, and advanced neurological deficit.
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Discussion
In this current review, we combined recent clinical data from 12 papers that directly compared surgical and medical management of SEA and used Reihsaus and colleagues's analysis of SEA cases reported from 1954 to 1997 as a historical control. 17 At the time of Reihsaus and colleagues's review, medical management was a common option, but most patients with an SEA were treated surgi- cally. The current data set was chosen to investigate the current trends of surgical versus medical management.
The demographics in the current data have remained similar to those reported by Reihsaus et al. 17 Males are still more commonly affected than females, and most abscesses are found in patients older than 50 years. Rank order of risk factors remained similar, with IV drug use continuing to be the most common risk factor. All risk factors for SEA were reported at significantly higher rates in the current literature than in the study by Reihsaus et al. 17 This could be attributed to the increase in the number of patients using IV drugs reporting to emergency departments. 23 In addition, the information available in published cases is limited in comparison with data found in patients' charts, and therefore may lead to under-reporting of risk factors when pooling data.
Among medical comorbidities, diabetes, liver disease, renal disease, and cardiac disease afflicted a large number of patients with SEA. Each medical comorbidity in the current data was reported at higher percentages than in the data of Reihsaus et al. 17 This again could be due to the current trends in the rising incidence of diabetes, 6,9 liver cirrhosis, 16 end-stage renal disease, 5 and endocarditis. 2 The rise in obesity may also play a role due to its adjunct effects on multiple organ systems. The other explanation is, again, an underreporting of risk factors in case reports due to the lack of available medical history. Overall, the rise in risk factors and comorbidities may explain the rise in SEA over time, although no epidemiological values have been published since 1999 to confirm this hypothesis.
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Abscess location was fairly consistent between the current data set and the data set of Reihsaus et al., 17 with most abscesses located in the thoracic or lumbar spine. The statistically significant increase in the percentage of SEAs in the lumbosacral spine in the current data and the greater percentage of SEAs in the thoracolumbar spine in the Reihsaus et al. data may be due to a matter of reporting. Due to abscesses often encompassing multiple segments, not every paper had a consistent, standard requirement for what was included in the thoracolumbar or lumbosacral spine. Overall, both the Reihsaus et al. data and the current data indicate that most abscesses are located in the thoracic to sacral spine, with most SEAs occurring at the thoracolumbar junction as opposed to the cervicothoracic junction.
Pathogens in the blood and tissue cultures remained fairly consistent, with Staphylococcus species being the most common pathogens. Although not specifically reported in our current data, Reihsaus et al. 17 found that coinciding infection was reported in 44% of cases, with the most common being skin infections or furuncles. This is one possible explanation for S. aureus as the leading bacterial cause of SEA. In addition, both IV drug use and diabetes increase the risk of skin infections. Thus, both medical comorbidities and risk factors contribute to the seeding of bacteria in spinal infections. Other bacteria associated with SEA include Streptococcus and coagulasenegative Staphylococcus, both common skin flora. The presence of gram-negative bacteria could be explained by local abdominal or urinary tract infections.
Presenting symptoms were reported to stratify patients and examine the use of MRI in obtaining early diagnosis to facilitate the institution of early, conservative SEA management. Currently and historically, the most common chief complaint among patients with SEA was back pain. 17 Almost half of the patients presented with varying degrees of weakness. The decrease in the percentage of patients reporting both back pain and motor weakness could suggest earlier diagnosis due to wider availability of MRI, * The values in parentheses indicate the number of patients for whom data on the specified variable were reported.
Fig. 2.
Comparison between patients undergoing surgical and medical management for treatment of SEA with historical control. Bar graph representing distribution of surgical to nonsurgical forms of treatment from current (pooled) data versus historical control. There was a significant difference in the proportions of treatment method implemented in the current studies over the historical control (p < 0.01).
Fig. 3.
Comparison of surgical and medical management given presenting deficits in patients with SEA. Group 1 included patients presenting without neurological deficit, with or without back pain. Group 2 included those presenting with neurological deficits, with or without back pain. The correlation between presenting deficits and management method was highly significant (Fisher's exact test, p < 0.01). reported combined med/surg outcomes only reported combined med/surg outcomes only NC * BI = Barthel Index; CRP = C-reactive protein; DBTO = difference between treatment outcomes; FMT = failure of medical treatment (requiring surgery); med = medical; NC = no statistical comparison; neurol = neurological; NSD = no statistically significant difference; sig = significant; SD = statistically significant difference; surg = surgical; Tx = treatment; WBC = white blood cell count.
but this does not explain the increase in reporting of other neurological sequelae, such as sensory abnormalities and bowel or bladder incontinence. This discrepancy indicates that the significant decrease in patients presenting with weakness and back pain could simply be due to a reporting bias. Most papers in the current data set retrospectively reported on back pain and weakness, but not all papers examined other neurological factors. For example, bowel or bladder incontinence was only reported in a patient pool of 127, but our total patient pool was 1099. Similarly, the Reihsaus et al. 17 data set relies extensively on case reports, which could be affected by the same reporting bias. Overall, these pooled data represent how most patients present, but due to the retrospective nature of the studies, the percentages may likely differ if SEA were studied prospectively. Because of the rarity and serious outcome of SEA, it remains impractical and unethical to conduct prospective, randomized controlled trials. We cannot rule out that the increasing trend in nonoperative management is due primarily to a shift in treatment philosophy, but the trend may be due to earlier diagnosis. There is a statistically significant decrease in the number of patients presenting with back pain and motor weakness after 1999 compared with the historical control. Improved imaging modalities may contribute to this significant change. However, our systematic analysis does not have the data to conclusively address the precise cause of the trend toward nonoperative management due to the aforementioned biases.
Surgical management continues to be the mainstay of treatment for SEA patients who present with deficits. Based on the currently presented data, significantly more patients have been treated conservatively after 1999. 12, 18 As suggested in our systematic analysis, there has been a paradigm shift to treat patients presenting with pain and no neurological deficits conservatively with close monitoring for worsening neurological deficits.
11 When comparing medically versus surgically managed cases of SEA, there were no significant differences between the number of cases in which the patients' condition improved, stayed the same, or worsened in several studies. 1 A definitive, conclusive comparison of the outcomes of medical and surgical management cannot be ascertained due to lack of uniformity of outcome data across the studies and the lack of prospective trials ( Table 7) . Furthermore, a fair comparison of our current aggregate outcome data cannot be made to the historical control because of the great variability in outcome methodology across the studies. 1, 3, 4, 7, 10, 11, 14, 20, 24 However, most of the individual studies in our analysis found no significant difference between surgically and medically managed patients.
There was one study that showed a better outcome for surgical than for medical management. 7 Curry et al. found a statistically significant difference between outcome of medical and surgical management, with 49% of patients initially treated with only medical therapy deteriorating in condition and requiring surgery. However, in their cohort of 23 patients treated medically, 9 patients (39%) initially presented with at least mild weakness but were not treated surgically for reasons that included delayed neurosurgical consultation, being poor surgical candidates, or misdiagnosis with psoas or chronic abscess. This high percentage skews the data toward failure of medical management even though initial surgical management would have likely served these patients better. These data highlight the importance of selecting a management strategy for patients based on the findings of their initial neurological examination.
Medical management was found to have a failure rate ranging from 6% to 49%, possibly due to differences in patient selection. 7, 11, 14, 19, 20 Overall, since many medically managed patients arrive neurologically intact, there should be a high degree of suspicion in evaluating for deterioration of their condition, particularly if they present with risk factors for failure of medical management. We developed a treatment algorithm based on these predictive risk factors and treatment paradigms offered in the literature (Fig. 4) . A large part of this algorithm is adapted from the study by Patel et al., 14 one of the only studies to use a standardized motor score for evaluating outcome.
Patel et al. used the ASIA motor score to evaluate medical versus surgical management of SEA.
14 When comparing the two groups, they found that medically and surgically managed patients had the same overall strength score. However, the condition of the surgically managed group improved to obtain that overall strength score, whereas the condition of the medically managed group stayed roughly the same posttreatment.
14 Interpretation of this finding is clouded by the fact that patients selected for operative management generally present with significant neurological deficits and usually improve dramatically after surgery, resulting in the same outcome as patients treated nonoperatively.
Patel et al. 14 also specifically considered the outcome of failed medical management requiring surgery. After this group of patients declined in condition following initial medical therapy, their ASIA motor score was lower than that originally seen in patients who either had successful medical management or were treated with early surgery. These patients ultimately had the lowest posttreatment ASIA motor scores. This underscores the importance of close observation for patients with risk factors who are treated medically. Had those patients been considered for surgery before the decline in their condition, they might have had better posttreatment outcomes, similar to those of other groups.
Based on the recent trend for more patients to receive medical management when presenting with only back pain and/or no weakness and our cumulative analysis demonstrating no significant difference in outcome between operative and nonoperative management, patients can be considered for medical management if they are neurologically intact at presentation, with close observation of those with the aforementioned risk factors.
Conclusions
Medical or conservative management for patients with SEA presenting without neurological deficit or spinal instability, and with improving infection, is a recent trend. Medically managed patients can deteriorate clinically and require closer observation, particularly if they have risk factors that make it more likely that medical treatment will fail in their cases. Future research may help further identify patients with SEA who are more likely to be successfully managed medically.
